2009 - The VEGF antagonist PRS-050 decreases vascular permeability in tumors and inhibits tumor growth: an analysis using dynamic contrast-enhanced magnetic resonance imaging

JF. Mirjoleta, B. Sourzata, X. Tizona, F. Bichata, A.M. Hohlbaumb and H. Gilleb

aOncodesign, bPieris

TELECHARGER

2009 - DDS-06E A novel oral pH-sensitive micellar formulation of SN38: Effect of dosing regimen on efficacy and tolerability using a human colon xenograft model

D. Le Garreca, C. Benqueta, D. Lessarda, L. Courtemanchea, D. Palusovaa, P. Kujawaa, F. Bichatb, O. Raguinb, V. Barib, S. Tagaa and D.C. Smitha

aLabopharm Inc., bOncodesign

TELECHARGER

2009 - Prostate cancer metabolism assessment by proton magnetic resonance spectroscopy (1H-MRS) and high resolution magic angle spinning spectroscopy (1H-HRMAS) in experimental rat models

P. Proventa, P. Walkerb, X. Tizona, N. Hoffmanna, S. Parfaitb, V. Lemaitrea, V. Baria, J. Miteranb, A. Tabardc, G. Créhanged, O. Duchampa and P. Gennea

aOncodesign, bLE2I/CNRS 5158, cICMUB, cCGFL

TELECHARGER

2009 - CReMEC initiative: Establishment and characterization of new in vivo models of human colorectal cancers

D. Goéréa,d, P. Marianib,d, M. Pocardc,d, L. Bigota,d, F. Nematib,d, D. Lantuasc,d, L. Morgandi, L. Lacroixa,d, S. Julieng, G. Prévostg, P. Gonina,d, V. Dangles-Marieb,c,d, A. Pierréf, A. Brunof, H. De Théh,d, H. Solimanh,d, A. Merino-Trigoe, G. Lardiere, H. Riquee, B. Demerse, C. Bertheti and O. Duchampi 

aInstitut Gustave Roussy, bInstitut Curie, cHôpital Lariboisière, dCancéropôle Ile de France, esanofi-aventis, fInstitut de recherche Servier, gIpsen, hHôpital St-Louis, iOncodesign

TELECHARGER